Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating

被引:397
作者
Cheung, King-Ho [1 ]
Shineman, Diana [2 ,4 ]
Mueller, Marioly [1 ]
Cardenas, Cesar [3 ]
Mei, Lijuan [1 ]
Yang, Jun [1 ]
Tomita, Taisuke [5 ]
Iwatsubo, Takeshi [5 ]
Lee, Virginia M. -Y. [2 ,4 ]
Foskett, J. Kevin [1 ,3 ]
机构
[1] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA
[4] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[5] Univ Tokyo, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan
关键词
D O I
10.1016/j.neuron.2008.04.015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mutations in presenilins (PS) are the major cause of familial Alzheimer's disease (FAD) and have been associated with calcium (Ca2+) signaling abnormalities. Here, we demonstrate that FAD mutant PS1 (M146L) and PS2 (N141I) interact with the inositol 1,4,5-trisphosphate receptor (InSP3R) Ca2+ release channel and exert profound stimulatory effects on its gating activity in response to saturating and suboptimal levels of InsP(3). These interactions result in exaggerated cellular Ca2+, signaling in response to agonist stimulation as well as enhanced low-level Ca2+, signaling in unstimulated cells. Parallel studies in InSP3R-expressing and -deficient cells revealed that enhanced Ca2+ release from the endoplasmic reticulum as a result of the specific interaction of PS1-M146L with the InSP3R stimulates amyloid beta processing, an important feature of AD pathology. These observations provide molecular insights into the "Ca2+ dysregulation" hypothesis of AD pathogenesis and suggest novel targets for therapeutic intervention.
引用
收藏
页码:871 / 883
页数:13
相关论文
共 67 条
[41]  
Mattson MP, 1997, J NEUROSCI RES, V50, P505
[42]   Neuronal and glial calcium signaling in Alzheimer's disease [J].
Mattson, MP ;
Chan, SL .
CELL CALCIUM, 2003, 34 (4-5) :385-397
[43]   Pathways towards and away from Alzheimer's disease [J].
Mattson, MP .
NATURE, 2004, 430 (7000) :631-639
[44]   ROLE OF CALCIUM-IONS IN REGULATION OF MAMMALIAN INTRAMITOCHONDRIAL METABOLISM [J].
MCCORMACK, JG ;
HALESTRAP, AP ;
DENTON, RM .
PHYSIOLOGICAL REVIEWS, 1990, 70 (02) :391-425
[45]   Culturing hippocampal and cortical neurons [J].
Meberg, PJ ;
Miller, MW .
NEURONS: METHODS AND APPLICATIONS FOR THE CELL BIOLOGIST, 2003, 71 :111-127
[46]   Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1 [J].
Nelson, Omar ;
Tu, Huiping ;
Lei, Tianhua ;
Bentahir, Mostafa ;
de Strooper, Bart ;
Bezprozvanny, Ilya .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) :1230-1239
[47]   Effect of γ-secretase inhibitors on muscarinic receptor-mediated calcium signaling in human salivary epithelial cells [J].
Oh, Young S. ;
Turner, R. James .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (01) :C76-C82
[48]   CALCIUM IONOPHORE INCREASES AMYLOID-BETA PEPTIDE PRODUCTION BY CULTURED-CELLS [J].
QUERFURTH, HW ;
SELKOE, DJ .
BIOCHEMISTRY, 1994, 33 (15) :4550-4561
[49]   Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease [J].
Scheuner, D ;
Eckman, C ;
Jensen, M ;
Song, X ;
Citron, M ;
Suzuki, N ;
Bird, TD ;
Hardy, J ;
Hutton, M ;
Kukull, W ;
Larson, E ;
LevyLahad, E ;
Viitanen, M ;
Peskind, E ;
Poorkaj, P ;
Schellenberg, G ;
Tanzi, R ;
Wasco, W ;
Lannfelt, L ;
Selkoe, D ;
Younkin, S .
NATURE MEDICINE, 1996, 2 (08) :864-870
[50]   Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation [J].
Schneider, I ;
Reversé, D ;
Dewachter, I ;
Ris, L ;
Caluwaerts, N ;
Kuipéri, C ;
Gilis, M ;
Geerts, H ;
Kretzschmar, H ;
Godaux, E ;
Moechars, D ;
Van Leuven, F ;
Herms, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :11539-11544